Deepbridge Capital

Deepbridge Capital aims to redefine the growth capital market by providing investors with access to opportunities in technology, life sciences, and renewable energy sectors, sourced, reviewed, and managed by their team of sector specialists. They focus on supporting energetic, passionate, and knowledgeable management teams to help their businesses achieve their full potential and provide optimum returns for investors. Deepbridge offers various investment products, including EIS and SEIS funds, catering to different risk profiles and investment goals. The firm places emphasis on understanding the operational aspects of investee companies to effectively support, mentor, and manage those businesses through their funding journey, from seed stage through commercialization and growth funding. Deepbridge uses a rigorous investment process, including a Supervisory Investment Committee which provides oversight on the technical and commercial elements of proposed and executed investments. This committee, comprised of Deepbridge executives and independent experts, ensures investments align with the mandate of their products and services. They emphasize a culture of professional excellence and integrity, encouraging investee companies to achieve the highest standards of corporate governance. They aim to mitigate risk through deep due diligence, sectoral expertise, and active management. They offer the FlexEIS, a revolutionary approach enabling financial advisers to recommend investments in the Deepbridge Life Sciences EIS and Deepbridge Technology Growth EIS funds, aligning growth-focused venture capital with regular financial planning. This method allows investors to benefit from the tax reliefs of the Enterprise Investment Scheme (EIS) on an ongoing basis, rather than through traditional annual lump sum commitments, starting from £1,000 per month per fund. The firm also offers the Private Investor Network enabling experienced investors to define their own portfolio of innovative Life Sciences and Technology companies. Tax benefits are a key component of Deepbridge's investment offerings. They highlight the potential for 30% income tax relief, capital gains tax deferral, no capital gains tax on disposal of shares held for at least three years, inheritance tax exemption, and loss relief. They actively use the Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS) to provide tax advantages to investors. Deepbridge manages various products based on SEIS and EIS criteria, providing opportunities to participate in portfolios of seed-stage technology innovation companies, growth-focused technology companies, and healthcare innovation companies, while taking advantage of potential tax benefits.

Technology, Life Sciences, Renewable Energy

Core thematic spaces, technologies, and target market segments of interest.